Barcelona 23 August 2013 - Dr Rafael Rosell's career and tireless work in the field of translational oncology in non-small-cell lung cancer were profiled in an interview in the prestigious journal The Lancet today, alongside the publication of an invited review by Dr Rosell detailing the state of the art in genetics and biomarkers and their application in personalized lung cancer treatment.
 
The publications were timed in advance of the annual European Respiratory Society congress, held this year in Barcelona between the 7th and 11th of September, at which Dr Rosell is a speaker.
 
Concurrently, Dr Rosell was also profiled in the Catalan daily, La Vanguardia.
Rafael Rosell: leading the long march against lung cancerGenetics and biomarkers in personalisation of lung cancer treatment'The Lancet' sitúa a Rosell como máximo líder europeo en cáncer de pulmónEuropean Respiratory Society congress 2013